Tompkins Financial’s Zimmer Biomet ZBH Stock Holding History

Tompkins Financial’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.89K	Hold	80	–	–	﹤0.01%	480
2026 Q1	$7.23K	Hold	80	–	–	﹤0.01%	474
2025 Q4	$7.19K	Sell	80 -50	-38%	-$4.74K	﹤0.01%	469
2025 Q3	$12.8K	Sell	130 -100	-43%	-$9.91K	﹤0.01%	425
2025 Q2	$21K	Buy	230 +50	+28%	+$4.83K	﹤0.01%	386
2025 Q1	$20.4K	Sell	180 -50	-22%	-$5.35K	﹤0.01%	402
2024 Q4	$24.3K	Sell	230 -400	-63%	-$42.9K	﹤0.01%	374
2024 Q3	$68K	Hold	630	–	–	0.01%	310
2024 Q2	$68.4K	Hold	630	–	–	0.01%	315
2024 Q1	$83.1K	Hold	630	–	–	0.01%	303
2023 Q4	$76.7K	Buy	630 +200	+47%	+$22.3K	0.01%	300
2023 Q3	$48.3K	Hold	430	–	–	0.01%	324
2023 Q2	$62.6K	Hold	430	–	–	0.01%	312
2023 Q1	$55.6K	Sell	430 -245	-36%	-$30.8K	0.01%	326
2022 Q4	$86K	Hold	675	–	–	0.01%	281
2022 Q3	$71K	Hold	675	–	–	0.01%	296
2022 Q2	$71K	Hold	675	–	–	0.01%	300
2022 Q1	$86K	Buy	675 +423	+168%	+$51K	0.01%	302
2021 Q4	$31K	Hold	252	–	–	0.01%	245
2021 Q3	$36K	Buy	+252	New	+$37.1K	0.01%	249
2021 Q1	$39K	Hold	252	–	–	0.01%	271
2020 Q4	$38K	Hold	252	–	–	0.01%	269
2020 Q3	$33K	Hold	252	–	–	0.01%	271
2020 Q2	$29K	Hold	252	–	–	0.01%	269
2020 Q1	$25K	Hold	252	–	–	0.01%	275
2019 Q4	$37K	Hold	252	–	–	0.01%	277
2019 Q3	$34K	Hold	252	–	–	0.01%	256
2019 Q2	$29K	Sell	252 -124	-33%	-$14.5K	0.01%	275
2019 Q1	$47K	Sell	376 -103	-22%	-$11.7K	0.01%	236
2018 Q4	$48K	Hold	479	–	–	0.01%	232
2018 Q3	$61K	Hold	479	–	–	0.01%	236
2018 Q2	$52K	Buy	479 +103	+27%	+$11.2K	0.01%	248
2018 Q1	$40K	Hold	376	–	–	0.01%	260
2017 Q4	$44K	Hold	376	–	–	0.01%	234
2017 Q3	$43K	Hold	376	–	–	0.01%	231
2017 Q2	$47K	Hold	376	–	–	0.01%	224
2017 Q1	$45K	Hold	376	–	–	0.01%	231
2016 Q4	$38K	Hold	376	–	–	0.01%	236
2016 Q3	$47K	Hold	376	–	–	0.01%	218
2016 Q2	$44K	Buy	376 +124	+49%	+$14K	0.01%	262
2016 Q1	$26K	Sell	252 -103	-29%	-$9.96K	0.01%	307
2015 Q4	$35K	Sell	355 -103	-22%	-$10.1K	0.01%	321
2015 Q3	$42K	Sell	458 -330	-42%	-$33.1K	0.01%	288
2015 Q2	$84K	Sell	788 -41	-5%	-$4.54K	0.02%	211
2015 Q1	$95K	Buy	829 +329	+66%	+$37.5K	0.02%	214
2014 Q4	$55K	Hold	500	–	–	0.01%	264
2014 Q3	$49K	Hold	500	–	–	0.01%	273
2014 Q2	$50K	Hold	500	–	–	0.01%	282
2014 Q1	$46K	Sell	500 -103	-17%	-$9.49K	0.01%	290
2013 Q4	$55K	Sell	603 -355	-37%	-$30.7K	0.01%	266
2013 Q3	$76K	Buy	958 +41	+4%	+$3.23K	0.02%	199
2013 Q2	$67K	Buy	+917	New	+$68.6K	0.02%	203

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Tompkins Financial's ZBH Position: Q2 2026 in Review

Tompkins Financial held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 80 shares worth $6.89K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

Tompkins Financial first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $95K in Q1 2015. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Tompkins Financial held 80 shares of Zimmer Biomet worth $6.89K as of Q2 2026.
Tompkins Financial left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Tompkins Financial's portfolio in Q2 2026, its #480 holding.
Tompkins Financial first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
Tompkins Financial's Zimmer Biomet position peaked at $95K in Q1 2015.
132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.